Angiotensin converting enzyme inhibitor improves nephrotic syndrome associated with cyanotic congenital heart disease
Watanabe, Y.; Fukuzawa, Y.; Inaguma, D.
Clinical Nephrology 45(5): 362-363
1996
ISSN/ISBN: 0301-0430 PMID: 8738675 Document Number: 458386
Document emailed within 1 workday
Related Documents
Zagidullin, N.S.; Valeeva, K.F.; Zagidullin, S.Z.; Rezbaeva, A.G. 2010: Possibilities of the use Angiotensin converting enzyme inhibitor in peripheral arterial disease Kardiologiia 50(4): 92-96Al-Omran, M.; Lindsay, T.F. 2005: Should all patients with peripheral arterial disease be treated with an angiotensin-converting enzyme inhibitor? Canadian Journal of Cardiology 21(2): 189-193
Bakaev, R.G.; Strutynskiĭ, A.V.; Kallaeva, A.N.; Glazunov, A.B.; Voronina, M.A.; Pekhtereva, D.A.; Moshkova, N.K.; Chudnovskaia, E.A.; Kochetkov, B.M. 2011: Effects of long-term therapy with angiotensin-converting enzyme inhibitor and carvedilol on the heart remodeling process after non-Q-wave myocardial infarction Klinicheskaia Meditsina 89(1): 23-26
Stanek, E.J.; Nara, A.R.; Strohl, K.P.; Nair, R.N.; Decker, M.J.; Munger, M.A. 1994: Effect of long-term angiotensin-converting enzyme inhibitor therapy on arterial oxygen saturation in patients with mild to moderate heart failure PharmacoTherapy 14(3): 321-329
Zhang, G.-h.; Hou, F.-f.; Zhang, X.; Liu, Q.-f. 2005: Can angiotensin-converting enzyme inhibitor be used in chronic kidney disease patients with serum creatinine level greater than 266 micromol/L? Zhonghua Nei Ke Za Zhi 44(8): 592-596
Renke, M.; Rutkowski, Pław.; Tylicki, L.; Zietkiewicz, M.; Larczyński, W.; Rutkowski, Bław. 2008: Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline Przeglad Lekarski 65(6): 312-314
Anantharaman, R.; Bhansali, A.; Bhadada, S.K.; Kohli, H.S.; Dutta, P.; Walia, R.; Jayaprakash, P.; Upreti, V. 2010: Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor and angiotensin receptor blocker in type 1 DM with nephropathy Indian Journal of Medical Research 132: 42-47
Iimura, O.; Kusano, E.; Tanba, K.; Yanagiba, S.; Amemiya, M.; Ando, Y.; Honma, S.; Muto, S.; Asano, Y. 2003: Additive antiproteinuric effect of angiotensin Ii receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis Nihon Jinzo Gakkai Shi 45(5): 439-444
Kono, T.; Ikeda, F.; Oseko, F.; Imura, H.; Endo, J. 1978: Angiotensin i converting enzyme inhibitor and angiotensin Ii antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 36(11): 3613-3620
Papadopoulos, D.P.; Economou, E.V.; Makris, T.K.; Kapetanios, K.J.; Moyssakis, I.; Votteas, V.E.; Toutouzas, P.K. 2004: Effect of angiotensin-converting enzyme inhibitor on collagenolytic enzyme activity in patients with acute myocardial infarction Drugs under Experimental and Clinical Research 30(2): 55-65
Wang, L-chun.; Ma, H.; He, J-gui.; Liao, X-xue.; Chen, W-fang.; Leng, X-yu.; Ma, L.; Mai, W-yi.; Tao, J.; Zeng, W-tao.; Liu, J.; Dong, Y-gang.; Tang, A-li.; Feng, C. 2005: Effect of angiotensin converting enzyme inhibitor on the calcium transients and calcium handling proteins in ventricular myocytes from rats with heart failure Chinese Medical Journal 118(9): 731-737
Chalghoum, A.; Noichri, Y.; Mohamed, M.Hadj.; Dandana, A.; Baudin, B.; Ferchichi, S.; Miled, Aédi. 2012: The pro-oxidant effect of angiotensin-1 converting enzyme in Tunisian patients with coronary heart disease Acta Bio-Medica: Atenei Parmensis 83(3): 202-207
Diskin, C.J.; Stokes, T.J.; Dansby, L.M.; Radcliff, L.; Carter, T.B. 2007: Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker? Journal of Nephrology 20(4): 410-416
Zhang, R.-y.; Huang, Y.-l.; Sun, Y.-h. 2005: Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase Zhonghua Yi Xue Za Zhi 85(15): 1053-1056
Antelava, N.A.; Gongadze, N.V.; Gogolauri, M.I.; Kezeli, T.D.; Pachkoriia, K.Z. 2007: Comparative characteristic of angiotensin-converting enzyme inhibitor--captopril and the angiotensin Ii receptor blokers--losartan action on the oxidative metabolism in experimental hyperlipidemia in rabbits Georgian Medical News 150: 57-60
Haghfelt, T. 1994: Trandolapril--a new angiotensin-converting enzyme inhibitor Ugeskrift for Laeger 156(42): 6232-6235
Dzau, V.I. 1989: Quinapril--a new angiotensin-converting enzyme inhibitor: an overview Angiology 40(4 Pt 2): 329-330
Bajaj, A.K. 1988: Enalapril: a second-generation angiotensin converting enzyme inhibitor American Journal of the Medical Sciences 296(5): 332-335
Goracy, I. 2000: Polymorphism of genes coding for angiotensin i converting enzyme and methylenetetrahydrofolate reductase in patients with ischemic heart disease Annales Academiae Medicae Stetinensis 46: 97-108
Zou, K.; Michikawa, M.; Komano, H. 2010: Novel Abeta-converting activity of angiotensin-converting enzyme and its role in Alzheimer's disease Seikagaku. Journal of Japanese Biochemical Society 82(12): 1120-1124